the aid library

LIST OPTIONS

Filter

27698

Sort by:

Direction:

Download (24)

View PDF (20)

The Treatment of Heart Failure with Reduced Ejection Fraction

Berliner, D.; Hänselmann, A.; Bauersachs, J. Deutsches Ärzteblatt International (2020) CC

Background Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death. Methods This review is based on articles retrieved by a selective search in PubMed, as well as on r... more

Download (10)

View PDF (9)

Transient ischaemic attack (TIA)

National Health Service UK (2021) CC

Webpage about transient ischaemic attack, addressing symptoms, causes, diagnosis, treatment and prevention.

Download (31)

View PDF (14)

High Blood Pressure

MedlinePlus National Library of Medicine (2020) CC

What is blood pressure? Blood pressure is the force of your blood pushing against the walls of your arteries. Each time your heart beats, it pumps blood into the arteries. Your blood pressure is highest when your heart beats, pumping the blood. This is called systolic pressure. When your heart is a... more

Download (18)

View PDF (13)

WHO: Hypertension

World Health Organization WHO (2023) C_WHO

Key facts - An estimated 1.28 billion adults aged 30–79 years worldwide have hypertension, most (two-thirds) living in low- and middle-income countries - An estimated 46% of adults with hypertension are unaware that they have the condition. - Less than half of adults (42%) with hypertension are... more

Download (31)

View PDF (18)

Peripheral Artery Disease - Treatment

National Heart, Lung, and Blood Institute (2022) CC

Treatment plan

Download (22)

View PDF (15)

Global Initiative for Chronic Obstructive Lung Disease - Report 2023

Global Initiative for Chronic Obstructive Lung Disease – GOLD (2023) CC2

The aim of the GOLD Report is to provide a non-biased review of the current evidence for the assessment, diagnosis and treatment of people with COPD. One of the strengths of GOLD reports is the treatment objectives. These have stood the test of time, and are organized into two groups: objectives tha... more

Download (24)

View PDF (20)

Severe and Difficult Asthma: Diagnosis and Management—Challenges for a Low‐Resource Environment

Bush, A. Springer Link (2021) CC2

Severe and difficult asthma in a low- and middle-income country (LMIC) can relate to lack of availability of basic medications; potentially reversible factors such as poor adherence or comorbidities such as obesity inhibiting a good response to treatment; and (rarely) true severe, therapy-resistant ... more

Download (35)

View PDF (20)

Challenges in the Management of Bronchial Asthma Among Adults in Nigeria: A Systematic Review

Onyedum, C.C.; Ukwaja, K.N.; Desula, O.O.; Ezeudo, D. (2013) CC2

Asthma is a chronic inflammatory condition characterized by airway hyper-responsiveness to a variety of stimuli largely of allergic origin with reversible airflow limitation. The major clinical features of asthma are wheezing, shortness of breath, and cough. It is a major cause of impaired quality o... more

Download (27)

View PDF (30)

TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma

Miller, M. K.; Lee, J.H.; Blanc, P.D.; et al. (2006) CC2

The aim of the present study was to predict which patients with severe or difficult-to-treat asthma are at highest risk for healthcare utilisation can be predicted so as to optimise clinical management. Data were derived from 2,821 adults with asthma enrolled in The Epidemiology and Natural History ... more

Download (20)

View PDF (11)

Survey on the impact of comorbid allergic rhinitis in patients with asthma

Valovirta, E.; Pawankar, R. (2006) CC2

Allergic rhinitis (AR) and asthma are inflammatory conditions of the airways that often occur concomitantly. This global survey was undertaken to understand patient perspectives regarding symptoms, treatments, and the impact on their well-being of comorbid AR and asthma.

Download (24)

View PDF (65)

Information Sheet on Lung Health & TB in Africa

National Istitute for Health Research (2019) CC2

Globally, it is estimated that 1 billion people suffer from acute and chronic respiratory conditions, making them major causes of illness and death. Although there is a relative lack of data and evidence on lung diseases beyond tuberculosis (TB) in Sub-Saharan Africa (SSA), their estimated regional ... more

Download (31)

View PDF (84)

Asthma morbidity in Africa: Is it time to act to achieve asthma care for all?

Thembelihle Hlophe, S.; Stolbrink, M.; Govender, K.; et al. (2023) CC2

As we approach World Asthma Day on the May 2, 2023, we reflect on the theme “ Asthma Care for All”. Prevalence of Asthma is increasing amongst children, adolescents and adults. Under-diagnosis, underutilization of inhaled corticosteroids, inaccessibility of treatment, and unaffordability of medi... more

Download (36)

View PDF (93)

The reality of managing asthma in sub-Saharan Africa – Priorities and strategies for improving care

Mortimer, K.; Masekela, R.; Ozoh, O.; et al. (2022) CC2

Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati... more

Download (35)

View PDF (79)

2020 Brazilian Thoracic Association recommendations for the management of asthma

Menezes Pizzichini, M. M.; de Carvalho-Pinto, R. M.; Delfini Cançado, J. E.; et al. (2020) CC2

The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the... more

Download (24)

View PDF (58)

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

Chung, K. F.; Wenzel, S. E.; Brozek, J. L.; et al. (2022) CC2

The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and physiology, as well as sections on evaluation and tr... more

Download (30)

View PDF (22)

National Asthma Education Programme

National Asthma Education Programme (2012) CC2

The National Asthma Education Programme (or NAEP for short) was started in 2008. We are a registered Non-Profit Organisation that aims to disseminate impartial information about asthma diagnosis and treatment to health professionals and the South African public.

Download (31)

View PDF (27)

Asthma medicines and how they work

National Asthma Education Programme (2012) CC2

Asthma is a chronic lung disease, which means it cannot be cured. But with the right treatment asthma can be kept under control so that those affected area be to live completely normal lives enjoyingfull involvement in sport and all other activities.

Download (27)

View PDF (23)

Keeping Asthma under control

National Asthma Education Programme (2012) CC2

Asthma usually causes symptoms over a long period and cannot be cured. But asthma can be kept under control so that those affected are able to live enjoying full involvement in sport and all other avtivies. New guidelines for the treatment of asthma put effective control of asthma as the most import... more

Download (25)

View PDF (23)

Lung function tests in Asthma

Levin, M. National Asthma Education Programme (2012) CC2

Asthma is a very commom condition. It cannot be cured, but can controlled with effective medication, good technique, and good monitoring by the patients are having no or few symptoms, no attacks needingg hospital visits and no or little emergency reliever medication use. Another way of assessing ast... more

Download (17)

View PDF (18)

Fig. 1: GINA treatment recommendations for patients aged ≤5 years, 6–11 years and ≥12 years

npj Primary Care Respiratory Medicine (2020) CC2

Adults and adolescents 12+ years. Asthma medication options: Adjust treatment up and down for individual patient needs